丁笠
+
Date of Birth:1986-09-04
Gender:Male
Education Level:With Certificate of Graduation for Doctorate Study
Alma Mater:中国药科大学
Scientific Research
Current position:
Home
/
Scientific Research
Research Field
- No content
Paper Publications
- Ding Li,邓彬,陈刚.RNA therapeutics targeting PD-L1 is a promising immune-activation strategy against difficult-to-treat cancers.MOLECULAR THERAPY,2024,32(8)2439-2440.
- Ding Li,徐玉洁,徐林,赵晨宏,张智萍,张杰,张新跃,廖凯.Programmed cell death 11 modulates but not entirely relies on p53-HDM2 loop to facilitate G2/M transition in colorectal cancer cells.ONCOGENESIS,2023,12(1)
- Ding Li,赵晨宏,徐玉洁,张智萍,聂也森,廖凯,Xinyue Zhang,陈玥柔.Mutations in DNA binding domain of p53 impede RSL1D1-p53 interaction to escape from degradation in human colorectal cancer cells.EXPERIMENTAL CELL RESEARCH,2022,417(1)
- Ding Li,高清清,许卓斌,蔡良良,陈素娟,Xinyue Zhang,曹鹏,陈刚.An Inter-Supplementary Biohybrid System Based on Natural Killer Cells for the Combinational Immunotherapy and Virotherapy of Cancer.ADVANCED SCIENCE,2022,9(2)
- Ding Li,徐玉洁,徐林,赵晨宏,张智萍,张杰,Xinyue Zhang,廖凯.Programmed cell death 11 modulates but not entirely relies on p53-HDM2 loop to facilitate G2/M transition in colorectal cancer cells.ONCOGENESIS,2023,12(1)
Patents
- No content
Published Books
- No content
Research Projects
- No content
